NSE filing, NSE: ABCAPITAL. Summary written from the filing by ALFA Finder's alert engine.
Aditya Birla Capital Ltd: key numbers
- Share price
- ₹356.00
- Market cap
- ₹97,473 Cr
- Revenue (annual)
- ₹45,509 Cr
- Net profit (annual)
- ₹3,764 Cr
- P/E (TTM)
- 23.8×Sector 21.7×
- Promoter holding
- 68.82%+0.01% QoQ
- FII holding
- 8.26%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Aditya Birla Capital Ltd
All →Aditya Birla Capital Debt & Borrowing
Aditya Birla Capital Limited fixed record dates for interest payments on various NCD series due in December 2026.
Aditya Birla Capital Other Announcement
Aditya Birla Capital Ltd filed its quarterly shareholding pattern as mandated by SEBI regulations for the period ended September 30, 2026.
Aditya Birla Capital Board Meeting Date
Aditya Birla Capital Limited scheduled a board meeting for October 30, 2026, to consider and approve unaudited financial results for the half-year ended September 2026.
Aditya Birla Capital Debt & Borrowing: ₹118.7 Cr
Aditya Birla Capital paid Rs. 118.65 Crore interest on its NCD Series 'G1'. This filing fulfills the mandatory debt servicing disclosure.
- Value
- ₹118.7 Cr
Aditya Birla Capital Debt & Borrowing: ₹13.51 Cr
Aditya Birla Capital clarified the interest amount as ₹2.79 crore for its NCD series II, alongside confirming the ₹10.73 crore redemption payment.
- Value
- ₹13.51 Cr
Aditya Birla Capital Debt & Borrowing: ₹216 Cr
Aditya Birla Capital has fully redeemed its secured NCDs (Series I and Series II), involving a total payout of ₹216.04 Crore.
- Value
- ₹216.0 Cr
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date